
Aems designs and runs high-throughput experiments for concentrated-biologic formulations, using approved marketed-drug excipients; its platform gives development teams needed data.
aemscorp.comCrawled Sep 27, 2026
From next-generation biologics to advanced materials, breakthrough science is pushing boundaries every day. But in order for innovations to make an impact, they need to flow. Literally.
AEMS Corp introduces an automated microscale platform for high-throughput screening of excipient combinations to reduce viscosity in biologic therapeutics. The system allows efficient testing of formulations, addressing a key bottleneck in drug development. Dr. Scott Compel and Dr. Alex Hendricks highlight its innovative approach to optimizing excipient performance.
May 2026ONdrugDeliveryNews article
CSU Spur’s first startup relocates to a larger facility to support its expanding operations. The move reflects steady growth since its founding at the Colorado State University innovation campus. The transition marks a milestone for the university-backed accelerator program.
Oct 2025SOURCENews article
AEMS Corp operates out of CSU Spur, marking the first startup to lease wet lab space through the CSU Spur Agricultural Innovation Center. The move establishes CSU Spur as a hub for agricultural innovation and industry collaboration.
Jul 2023SOURCENews article
Advanced Industries awarded **AEMS Corp.** a **$250,000 grant** to advance its sanitizer technology. The Boulder-based startup’s products target harmful bacteria on sprout seeds before germination, improving food safety. The funding supports Colorado’s growing agtech and biosecurity innovation ecosystem.
May 2023Colorado Office of Economic Development and International TradeNews article